A5087014245- Cardiovascular Health and Risk Factors
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Birth, Development, and Health
- Pregnancy and preeclampsia studies
- Gestational Diabetes Research and Management
- Health disparities and outcomes
- Blood Pressure and Hypertension Studies
- Cardiovascular Issues in Pregnancy
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Cardiovascular Disease and Adiposity
- Cardiac Health and Mental Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiac Imaging and Diagnostics
- Transplantation: Methods and Outcomes
- Cardiac pacing and defibrillation studies
- Maternal and fetal healthcare
- Liver Disease Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Nutritional Studies and Diet
- Viral Infections and Immunology Research
- Lipoproteins and Cardiovascular Health
- Cardiomyopathy and Myosin Studies
- Healthcare Policy and Management
Northwestern University
2016-2025
National Heart Lung and Blood Institute
2024-2025
Island Institute
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
2024
Northwestern Medicine
2022-2024
Heart Foundation
2024
Michael E. DeBakey VA Medical Center
2024
University of Illinois Chicago
2023
Central University of Venezuela
2023
Huazhong University of Science and Technology
2023
The American Heart Association, in conjunction with the National Institutes of Health, annually reports on most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data a range major clinical circulatory disease conditions (including congenital rhythm disorders,...
The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders,...
The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders,...
Prior studies have demonstrated lower all-cause mortality in individuals who are overweight compared with those normal body mass index (BMI), but whether this may come at the cost of greater burden cardiovascular disease (CVD) is unknown.To calculate lifetime risk estimates incident CVD and subtypes to estimate years lived without by weight status.In population-based study, we used pooled individual-level data from adults (baseline age, 20-39, 40-59, 60-79 years) across 10 large US...
Signs and symptoms of congestion are the most common cause for hospitalization heart failure (HHF). The clinical course prognostic value during HHF has not been systemically characterized. A post hoc analysis was performed placebo group (n = 2061) EVEREST trial, which enrolled patients within 48 h admission (median ∼24 h) worsening HF with an EF ≤40% two or more signs fluid overload [dyspnoea, oedema, jugular venous distension (JVD)] a median follow-up 9.9 months. Clinician-investigators...
Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms functional limitations, poor quality life. By targeting cardiometabolic abmormalities, sodium glucose cotransporter 2 (SGLT2) inhibitors may improve these impairments. In this multicenter, randomized trial patients HFpEF (NCT03030235), we evaluated whether the SGLT2 inhibitor dapagliflozin improves primary endpoint Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CS),...
BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current have several limitations. Therefore, we developed and validated the American Heart Association Predicting Risk CVD EVENTs (PREVENT) among US adults 30 79 years age without known CVD. METHODS: The derivation sample included individual-level participant data from 25 sets (N=3 281 919) between 1992 2017. outcome was (atherosclerotic heart...
<h3>Importance</h3> Gestational diabetes is associated with adverse maternal and offspring outcomes. <h3>Objective</h3> To determine whether rates of gestational among individuals at first live birth changed from 2011 to 2019 how these differ by race ethnicity in the US. <h3>Design, Setting, Participants</h3> Serial cross-sectional analysis using National Center for Health Statistics data 12 610 235 aged 15 44 years singleton births <h3>Exposures</h3> stratified following groups:...
The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in management patients with hypertrophic cardiomyopathy.
Background Although historical trends before 1998 demonstrated improvements in mortality caused by pulmonary embolism (PE), contemporary estimates of are unknown. Therefore, our objective is to describe death rates PE the United States, overall and sex‐race, regional, age subgroups. Methods Results We used nationwide certificate data from Centers for Disease Control Prevention Wide‐Ranging Online Data Epidemiologic Research calculate age‐adjusted as underlying cause 1999 2018. Joinpoint...